CD300a Protein (CD300A)
-
- 抗原 See all CD300a (CD300A) 蛋白
- CD300a (CD300A)
- 蛋白类型
- Recombinant
-
宿主
- 人
-
资源
- 大肠杆菌（E. Coli）
- 应用范围
- SDS-PAGE (SDS)
- 纯度
- > 90 % pure
- Top Product
- Discover our top product CD300A 蛋白
-
CD300a (CD300A) (AA 18-180) protein (His tag)
CD300A 宿主: 人 宿主: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
CD300a (CD300A) (AA 18-180) protein (Fc Tag)CD300A 宿主: 人 宿主: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
CD300a (CD300A) (AA 28-185) protein (Fc Tag)CD300A 宿主: 小鼠 宿主: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
CD300a (CD300A) (AA 28-185) protein (His tag)CD300A 宿主: 小鼠 宿主: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
CD300a (CD300A) (AA 1-299) protein (GST tag)CD300A 宿主: 人 宿主: 小麦胚 Recombinant WB, ELISA, AP, AA
-
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 500 μg/mL
- 缓冲液
- Supplied in liquid form in 20 mM Tris-HCl buffer ( pH 8.0) containing 0.15M NaCl, 10 % glycerol, 1 mM DTT
- 储存液
- Dithiothreitol (DTT)
- 注意事项
- This product contains Dithiothreitol (DTT): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C/-20 °C/-80 °C
-
- 抗原
- CD300a (CD300A)
- 别名
- CD300A (CD300A 产品)
- 别名
- CD300L-B1 Protein, CD300A Protein, clm8 Protein, B230315M08Rik Protein, Clm8 Protein, LMIR1 Protein, MAIR-I Protein, MAIR-Ia Protein, MMAC8 Protein, Pigr4 Protein, mcpir1 Protein, CLM-8 Protein, CMRF-35-H9 Protein, CMRF-35H Protein, CMRF35-H Protein, CMRF35-H9 Protein, CMRF35H Protein, CMRF35H9 Protein, IGSF12 Protein, IRC1 Protein, IRC1/IRC2 Protein, IRC2 Protein, IRp60 Protein, CD300 molecule like family member g Protein, CD300a molecule Protein, CMRF35-like molecule 8 Protein, CD300A molecule Protein, Cd300a molecule Protein, CD300LG Protein, CD300A Protein, LOC483289 Protein, clm8 Protein, Cd300a Protein
- 分子量
- 14.7 kDa
- 途径
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-
